Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines Part 2-Reference-Cited by-同舟云学术

Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines Part 2

Published:2016 Issue:4 Volume:6 Page:193
ISSN:2093-6338
Container-title:Laboratory Medicine Online
language:ko
Short-container-title:Lab Med Online

Author:

Kim Sollip¹,Yun Yeo-Min²,Kim In-Suk³,Song Sang Hoon⁴,Woo Hye In⁵,Lee Kyung-A⁶,Lee Woochang⁷,Cho Hyun-Jung⁸,Ji Misuk⁹,Chae Hyo-Jin¹⁰,Lee Soo-Youn¹¹,Chun Sail⁷

Affiliation:

1. Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea.

2. Department of Laboratory Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea.

3. Department of Laboratory Medicine, School of Medicine, Pusan National University, Busan, Korea.

4. Department of Laboratory Medicine, Seoul National University Hospital and College of Medicine, Seoul, Korea.

5. Department of Laboratory Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea.

6. Department of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.

7. Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea.

8. Department of Laboratory Medicine, Konyang University Hospital, College of Medicine, Konyang University, Daejeon, Korea.

9. Department of Laboratory Medicine, Veterans Health Service Medical Center, Seoul, Korea.

10. Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.

11. Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publisher

Laboratory Medicine Online

Subject

Industrial and Manufacturing Engineering

Link

http://synapse.koreamed.org/pdf/10.3343/lmo.2016.6.4.193

Reference134 articles.

1. Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

2. Warfarin Pharmacology, Clinical Management, and Evaluation of Hemorrhagic Risk for the Elderly

3. Effect ofVKORC1Haplotypes on Transcriptional Regulation and Warfarin Dose

4. National Estimates of Emergency Department Visits for Hemorrhage-Related Adverse Events From Clopidogrel Plus Aspirin and From Warfarin

5. FDA. Food and Drug Administration. New labeling information for warfarin (marketed as Coumadin). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152972.htm

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for Clinical Application of Pharmacogenetic Test Results Interpretation by Clinical Laboratories;Laboratory Medicine Online;2022-10-01

2. NUDT15 Genotyping in Thiopurine Drug Therapy;Laboratory Medicine Online;2022-10-01

3. Portal Biliopathy Misdiagnosed as Hilar Cholangiocarcinoma;The Korean Journal of Gastroenterology;2022-07-25

4. Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines;Annals of Laboratory Medicine;2017-03-01